Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype

被引:123
作者
Galbiati, F
Volonté, D
Chu, JB
Li, M
Fine, SW
Fu, MF
Bermudez, J
Pedemonte, M
Weidenheim, KM
Pestell, RG
Minetti, C
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Neuropathol & Pathol, Bronx, NY 10461 USA
[5] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[6] Univ Genoa, Ist Gastlili, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy
关键词
D O I
10.1073/pnas.160249097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It recently was reported that Duchenne muscular dystrophy (DMD) patients and mdx mice have elevated levels of caveolin-3 expression in their skeletal muscle. However, it remains unknown whether increased caveolin-3 levels in DMD patients contribute to the pathogenesis of DMD. Here, using a genetic approach, we test this hypothesis directly by overexpressing wild-type caveolin-3 as a transgene in mice, Analysis of skeletal muscle tissue from caveolin-3- overexpressing transgenic mice reveals: (i) a dramatic increase in the number of sarcolemmal muscle cell caveolae; (ii) a preponderance of hypertrophic, necrotic, and immature/regenerating skeletal muscle fibers with characteristic central nuclei; and (iii) down-regulation of dystrophin and beta-dystroglycan protein expression. In addition, these mice show elevated serum creatine kinase revels, consistent with the myo-necrosis observed morphologically. The Duchenne-like phenotype of caveolin-3 transgenic mice will provide an important mouse model for understanding the pathogenesis of DMD in humans.
引用
收藏
页码:9689 / 9694
页数:6
相关论文
共 49 条
[1]   Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[2]  
BONILLA E, 1981, AM J PATHOL, V104, P167
[3]   X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY (MDX) IN THE MOUSE [J].
BULFIELD, G ;
SILLER, WG ;
WIGHT, PAL ;
MOORE, KJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04) :1189-1192
[4]  
CHANG HW, 1989, J BIOL CHEM, V264, P20831
[5]   Motor dysfunction in a mouse model for Down syndrome [J].
Costa, ACS ;
Walsh, K ;
Davisson, MT .
PHYSIOLOGY & BEHAVIOR, 1999, 68 (1-2) :211-220
[6]   Molecular and cellular biology of caveolae - Paradoxes and plasticities [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Scherer, PE ;
Lisanti, MP .
TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (04) :103-110
[7]   Caveolin-3 is not an integral component of the dystrophin glycoprotein complex [J].
Crosbie, RH ;
Yamada, H ;
Venzke, DP ;
Lisanti, MP ;
Campbell, KP .
FEBS LETTERS, 1998, 427 (02) :279-282
[8]   Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3) - Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/731) [J].
Engelman, JA ;
Zhang, XL ;
Galbiati, F ;
Lisanti, MP .
FEBS LETTERS, 1998, 429 (03) :330-336
[9]   Molecular genetics of the caveolin gene family:: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy [J].
Engelman, JA ;
Zhang, XL ;
Galbiati, F ;
Volonté, D ;
Sotgia, F ;
Pestell, RG ;
Minetti, C ;
Scherer, PE ;
Okamoto, T ;
Lisanti, MP .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (06) :1578-1587
[10]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381